06:06 AM EDT, 10/29/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) is close to acquiring drug trial software maker Clario in an all-cash deal that could value the healthcare technology group at about $10 billion, the Financial Times reported Tuesday, citing people familiar with the matter.

A deal could be announced as early as Wednesday, two sources told the FT.

Thermo Fisher and Clario didn't immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)